EUVIMEDEUVIMED entdecken
Crossref

Unveiling NRlncRNAs as prognostic biomarkers and therapeutic targets for head‐and‐neck squamous cell carcinoma through machine learning

Jiao Shao iD, Bo Xiong, Deru Lei, Xiaojian Chen

Environmental Toxicology · 2024

DOI: 10.1002/tox.24108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Toxicology, 2024. Verfasst von Jiao Shao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Head and Neck Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Medical health science and technology plan projects in Wenzhou (Y20210102), Foundation of Wenzhou Medical University (202102242015).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head‐and‐neck squamous cell carcinoma (HNSCC) patients often exhibit insensitivity to immunotherapy, leading to treatment failure. Identifying potential biomarkers that can predict prognosis and improve the efficacy of treatment is crucial. In this study, we aimed to identify necroptosis‐related long noncoding RNAs (NRlncRNAs) as potential therapeutic targets to improve the prognosis of HNSCC patients. By exploring the Genotype‐Tissue Expression Project (GTEx) and the Cancer Genome Atlas (TCGA) databases, we identified NRlncRNAs and developed a risk model comprising 17 NRlncRNAs to predict the prognosis of HNSCC patients and to classify patients into two clusters based on their expression levels. We conducted various analyses, such as the Kaplan–Meier analysis, GSEA and IC50 prediction, to evaluate the differences in sensitivity to immunotherapy between the two clusters. Our findings suggest that NRlncRNAs have potential as therapeutic targets for improving the prognosis of HNSCC patients, and that individualized treatment approaches based on NRlncRNA expression levels can improve the sensitivity of immunotherapy and overall treatment outcomes. This study highlights new perspectives within clinical cancer informatics and provides insight into potential therapeutic strategies for HNSCC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingHead and Neck NeoplasmsHumansSquamous Cell Carcinoma of Head and NeckPrognosisMachine LearningBiomarkers, TumorGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

NRlncRNAshead and neck squamous cell carcinomamachine learningprognostic biomarkerstherapeutic targets

Substanzen

RNA, Long NoncodingBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
  • The First Affiliated Hospital of Harbin Medical University, School of Stomatology, Harbin Medical University, Harbin, China.

ORCID-Profile: Jiao Shao

Förderung

  • Medical health science and technology plan projects in Wenzhou (Y20210102)
  • Foundation of Wenzhou Medical University (202102242015)

Zitieren

APA

Shao, J., Xiong, B., Lei, D., & Chen, X. (2024). Unveiling NRlncRNAs as prognostic biomarkers and therapeutic targets for head‐and‐neck squamous cell carcinoma through machine learning. Environmental Toxicology. https://doi.org/10.1002/tox.24108

Vancouver

Shao J, Xiong B, Lei D, Chen X. Unveiling NRlncRNAs as prognostic biomarkers and therapeutic targets for head‐and‐neck squamous cell carcinoma through machine learning. Environmental Toxicology. 2024. doi:10.1002/tox.24108

BibTeX
@article{Shao2024,
  author = {Shao, Jiao and Xiong, Bo and Lei, Deru and Chen, Xiaojian},
  title = {Unveiling NRlncRNAs as prognostic biomarkers and therapeutic targets for head‐and‐neck squamous cell carcinoma through machine learning},
  journal = {Environmental Toxicology},
  year = {2024},
  doi = {10.1002/tox.24108}
}
Kostenlos starten →